Cystadane
Product Images NDC 52276-401

4 FDA label images from Orphan Europe Sarl · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Cystadane (NDC 52276-401). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Orphan Europe Sarl, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cystadane Uk Bottle Label (Cystadane Uk Bottle Label)

Cystadane Uk Bottle Label (Cystadane Uk Bottle Label)
Packaging label for Cystadane 1 g powder by Orphan Europe SARL. The label includes the proprietary name, dosage strength of 1 g, and multiple language translations of the product name. Also shown are the EU authorization number and Orphan Europe and Recordati Group logos, along with the manufacturer's address in France.*
FDA Label Image

Cystadane Uk Carton (Cystadane Uk Carton)

Cystadane Uk Carton (Cystadane Uk Carton)
Cystadane 1 g oral powder packaging label displaying multilingual usage instructions and storage information. The label includes national flags indicating language regions and barcodes for the United Kingdom, Portugal, Latvia, Finland, Sweden, Denmark, Norway, and Iceland. The labeler is Orphan Europe SARL, with a purple gradient background and clear sections for each language.*
FDA Label Image

Cystadane Us Bottle Label (Cystadane Us Bottle Label)

Cystadane Us Bottle Label (Cystadane Us Bottle Label)
The packaging label for Cystadane (betaine anhydrous) oral solution powder provides details including the product name, active ingredient, and strength of 1 gram of betaine anhydrous powder per scoopful. It indicates a net quantity of 180 grams and shows manufacturing and licensing information from Orphan Europe SARL and Recordati Rare Diseases Inc. Preparation instructions with steps and simple illustrations are included for proper usage.*
FDA Label Image

Product Comparison (Product Comparison Table)

Product Comparison (Product Comparison Table)
A comparative text panel showing dosing and administration instructions for Cystadane from FDA-approved U.S. labeling and imported UK labeling. It details dosage amounts, administration methods, measuring scoops, and monitoring guidelines. Additionally, it describes packaging and storage information, including bottle size, child-resistant cap, and included scoops.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.